|
Volumn 27, Issue 8, 2009, Pages 710-721
|
Public biotech 2008the numbers
a a a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADALIMUMAB;
BEVACIZUMAB;
BORTEZOMIB;
CETUXIMAB;
ETANERCEPT;
IMATINIB;
INFLIXIMAB;
INSULIN GLARGINE;
NOVEL ERYTHROPOIESIS STIMULATING PROTEIN;
PNEUMOCOCCUS VACCINE;
RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;
RITUXIMAB;
ACUTE LYMPHOCYTIC LEUKEMIA;
ANEMIA;
ANKYLOSING SPONDYLITIS;
AUSTRALIA;
BIOTECHNOLOGY;
BRAIN CANCER;
BREAST CANCER;
CANADA;
CAPITAL;
CHRONIC MYELOID LEUKEMIA;
COLORECTAL CANCER;
COLORECTAL CARCINOMA;
CROHN DISEASE;
DERMATOFIBROSARCOMA PROTUBERANS;
DRUG INDICATION;
EMPLOYMENT;
EUROPE;
FINANCIAL MANAGEMENT;
FUNDING;
GASTROINTESTINAL STROMAL TUMOR;
HYPEREOSINOPHILIC SYNDROME;
INSULIN DEPENDENT DIABETES MELLITUS;
INVESTMENT;
JUVENILE RHEUMATOID ARTHRITIS;
LUNG NON SMALL CELL CANCER;
MASTOCYTOSIS;
MULTIPLE MYELOMA;
MYELODYSPLASTIC SYNDROME;
MYELOPROLIFERATIVE DISORDER;
NEUTROPENIA;
NON INSULIN DEPENDENT DIABETES MELLITUS;
NONHODGKIN LYMPHOMA;
PNEUMOCOCCAL INFECTION;
PRIORITY JOURNAL;
PROFIT;
PSORIASIS;
PSORIASIS VULGARIS;
PSORIATIC ARTHRITIS;
REVIEW;
RHEUMATOID ARTHRITIS;
STREPTOCOCCUS PNEUMONIAE;
ULCERATIVE COLITIS;
UNITED STATES;
ARTICLE;
COMMERCIAL PHENOMENA;
COOPERATION;
DRUG INDUSTRY;
ECONOMICS;
GEOGRAPHY;
LICENSING;
MARKETING;
ORGANIZATION AND MANAGEMENT;
RESEARCH;
BIOTECHNOLOGY;
COMMERCE;
COOPERATIVE BEHAVIOR;
DRUG INDUSTRY;
GEOGRAPHY;
LICENSURE;
MARKETING;
PUBLIC SECTOR;
RESEARCH;
|
EID: 68449102370
PISSN: 10870156
EISSN: 15461696
Source Type: Journal
DOI: 10.1038/nbt0809-710 Document Type: Review |
Times cited : (12)
|
References (0)
|